Replies to post #250801 on Biotech Values

[DewDiligence]

Re: VKTX valuation

At the AH price ($87.39 as I'm typing), VKTX has an EV of roughly $9.1B, based on 108.4M fully-diluted shares and ~$350M of net current assets on the 12/31/23 balance sheet:

https://www.sec.gov/ixviewer/ix.html?doc=/Archives/edgar/data/0001607678/000095017024012322/vktx-20231231.htm#balance_sheets (page F-12)

[DewDiligence]

VKTX sells—(upsized)—7.44M* shares @$85.00—essentially_no_discount_to_Tuesday’s_closing_price:

https://www.prnewswire.com/news-releases/viking-therapeutics-announces-pricing-of-550-million-public-offering-of-common-stock-302074989.html

Net proceeds will be ~$595M* after underwriting fees.

*Assuming exercising of underwriter’s option.